Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org
-- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Sunday, February 18, 2018
Systematic review of systematic reviews for medical cannabinoids: Pain, nausea and vomiting, spasticity, and harms.
Saturday, February 17, 2018
10 Tips to Combat Social Isolation in Multiple Sclerosis  Social Isolation is all too common amongst people with Multiple Sclerosis (MS). Dr. B offers 10 tips to combat social isolation: 10. participate in the online community. People who share your interests are out there on Twitter, Facebook, Instagram, YouTube and many many more. 9. Become a pen pal! 8. Set up a standing weekly phone date with a loved one or good friend 7. Complete some paperwork at a cafe instead of the home office 6. Take your workout outside of the home. Consider going to the park, taking group yoga or barre class, lifting at a rec center or joining a local gym. 5. Set up a standing monthly lunch date with a friend across town 4. Join a support group! Find a group right for you (ask your provider or check with the local NMSS chapter) 3. Sign up for a class at your community rec center! Underwater basket weaving at noon on Wednesdays! 2. Volunteer. It feels so good to give back. Usher at church, read to kids in a library, help with dinner at a soup kitchen. 1. The number one tip...GET A PET! Which tips sound right for you? What have you tried you could share with us? Please leave your own tips, your comments and questions below! #WeHaveMS
Multiple Sclerosis and Dogs: 7 reasons people with MS should own a dog Reason #7 is health benefits. Owning a dog lowers blood pressure, lowers depression, lowers anxiety and lowers stress levels. That's very cool! Reason #6 Many dogs can be trained as therapy dogs. There are many really cool video's on YouTube about therapy dogs. Check them out! Watch this video to learn 5 more reasons people with MS should own a dog! Do you own a dog? Have you identified benefits I left out? Please share with use! Kindly leave your questions and comments below! #WeHaveMS #PetsOfMS, #MSViewsandNews,
OhioHealth MS Center: http://ow.ly/GSUX30i2mtG YouTube: https://www.youtube.com/c/AaronBosterMD
Ipsen Announces Dysport® (abobotulinumtoxinA) Data Presentations Highlighting Duration of Response and Potential Benefit of Repeated Treatment in Spasticity
BASKING RIDGE, N.J., February 15, 2018 – Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY) (Ipsen), announced Dysport® (abobotulinumtoxinA) data will be presented today in two oral presentations at the annual meeting of the Association of Academic Physiatrists (AAP) being held in Atlanta, February 13-17, 2018. The oral presentations provide the outcomes of multiple Phase 3 studies that evaluated time to retreatment, as well as long-term treatment with Dysport® .
“The data being presented at this year’s AAP meeting indicate that Dysport® provides sustained spasticity relief for both adult and pediatric patients,” said David Cox, Vice President, US Medical Affairs, HEOR & Commercial Regulatory Affairs, Ipsen. “Improved outcomes from long-term therapy along with longer time between injections can be important factors in the management of these conditions, and we’re pleased to share these data to help inform physician and patient treatment decisions.”
In the first oral presentation, results from three randomized, placebo-controlled, double-blind Phase 3 studies of Dysport® evaluating time to retreatment in three patient groups showed that 37 percent of hemiparetic (post-stroke/traumatic brain injury) patients with adult upper limb spasticity (AULS), 20 percent of hemiparetic patients with adult lower limb spasticity (ALLS) and 74 percent of patients with pediatric (at least two years of age) lower limb spasticity (PLLS) due to cerebral palsy did not require reinjection until week 16 or later (Abstract #361196).
Learn more by clicking here
Wednesday, February 14, 2018